Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07374068
Eligibility Criteria:
Inclusion Criteria:
* Age ≥60 years
* Histologically confirmed Hodgkin lymphoma, including classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma
* Treatment-naïve patients who have not received prior anti-Hodgkin lymphoma therapy
* Availability of complete clinical, pathological, and follow-up data
Exclusion Criteria:
* Presence of other malignant tumors
* Severe hepatic or renal dysfunction (Child-Pugh class C or estimated glomerular filtration rate \<30 mL/min)
* Missing more than 20% of required clinical data
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT07374068
Study Brief:
Protocol Section:
NCT07374068